Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples
Corresponding Author
Armin Rashidi
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
These authors contributed equally to this work.Correspondence: Armin Rashidi, Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota, 14-100 PWB, MMC480, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
E-mail: [email protected]
Search for more papers by this authorRyan Shanley
Masonic Cancer Center Biostatistics Core, University of Minnesota, Minneapolis, MN, USA
These authors contributed equally to this work.Search for more papers by this authorSophia L. Yohe
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorBharat Thyagarajan
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorJulie Curtsinger
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorEdmund K. Waller
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorBart L. Scott
Fred Hutchinson Cancer Research Center, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA, USA
Search for more papers by this authorBruce R. Blazar
Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorDaniel J. Weisdorf
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorCorresponding Author
Armin Rashidi
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
These authors contributed equally to this work.Correspondence: Armin Rashidi, Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota, 14-100 PWB, MMC480, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
E-mail: [email protected]
Search for more papers by this authorRyan Shanley
Masonic Cancer Center Biostatistics Core, University of Minnesota, Minneapolis, MN, USA
These authors contributed equally to this work.Search for more papers by this authorSophia L. Yohe
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorBharat Thyagarajan
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorJulie Curtsinger
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorEdmund K. Waller
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorBart L. Scott
Fred Hutchinson Cancer Research Center, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA, USA
Search for more papers by this authorBruce R. Blazar
Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorDaniel J. Weisdorf
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorSummary
Host genetics shape the gut microbiota, and gut dysbiosis increases the risk of acute graft-versus-host disease (aGVHD). Paneth cells and microbiota have interactions that contribute to immune regulation. α-defensin-5 (HD5) and regenerating islet-derived protein 3 alpha (Reg3A) are the most abundant Paneth cell antimicrobial peptides (AMPs). We hypothesized that single nucleotide polymorphisms (SNPs) in the genes for HD5 (DEFA5) and Reg3A (REG3A) predict aGVHD risk. We analysed pre-transplant recipient peripheral blood mononuclear cell samples from randomized Blood and Marrow Transplant Clinical Trials Network (BMT CTN) studies 0201 (94 patients with bone marrow and 93 with peripheral blood grafts) and 0901 (86 patients with myeloablative and 77 with reduced-intensity conditioning; all using peripheral blood grafts). In multivariable analysis (with a SNP × graft source interaction term in CTN-0201 and a SNP × conditioning intensity term in CTN-0901), DEFA5 rs4415345 and rs4610776 were associated with altered incidence of aGVHD grade II–IV [rs4415345 G vs. C: hazard ratio (HR) 0·58, 95% confidence interval (95% CI) 0·37–0·92, P = 0·02; rs4610776 T vs. A: HR 1·53, 95% CI 1·01–2·32, P = 0·05] in CTN-0201, but not CTN-0901, suggesting a stronger effect in bone marrow allografts. REG3A SNP was not associated with aGVHD. Host genetics may influence aGVHD risk by modulating Paneth cell function.
References
- Anasetti, C., Logan, B.R., Lee, S.J., Waller, E.K., Weisdorf, D.J., Wingard, J.R., Cutler, C.S., Westervelt, P., Woolfrey, A., Couban, S., Ehninger, G., Johnston, L., Maziarz, R.T., Pulsipher, M.A., Porter, D.L., Mineishi, S., McCarty, J.M., Khan, S.P., Anderlini, P., Bensinger, W.I., Leitman, S.F., Rowley, S.D., Bredeson, C., Carter, S.L., Horowitz, M.M. & Confer, D.L.; for the Blood and Marrow Transplant Clinical Trials Network. (2012) Peripheral-blood stem cells versus bone marrow from unrelated donors. New England Journal of Medicine, 367, 1487–1496.
- Ayabe, T., Satchell, D.P., Wilson, C.L., Parks, W.C., Selsted, M.E. & Ouellette, A.J. (2000) Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nature Immunology, 1, 113–118.
- Blander, J.M., Longman, R.S., Iliev, I.D., Sonnenberg, G.F. & Artis, D. (2017) Regulation of inflammation by microbiota interactions with the host. Nature Immunology, 18, 851–860.
- Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R.P. & Pamer, E.G. (2007) MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. The Journal of Experimental Medicine, 204, 1891–1900.
- Cash, H.L., Whitham, C.V., Behrendt, C.L. & Hooper, L.V. (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (New York, N.Y.), 313, 1126–1130.
- Darnaud, M., Dos Santos, A., Gonzalez, P., Augui, S., Lacoste, C., Desterke, C., De Hertogh, G., Valentino, E., Braun, E., Zheng, J., Boisgard, R., Neut, C., Dubuquoy, L., Chiappini, F., Samuel, D., Lepage, P., Guerrieri, F., Doré, J., Bréchot, C., Moniaux, N. & Faivre, J. (2018) Enteric delivery of regenerating family member 3 alpha alters the intestinal microbiota and controls inflammation in mice with colitis. Gastroenterology, 154, e14.
- Eriguchi, Y., Takashima, S., Oka, H., Shimoji, S., Nakamura, K., Uryu, H., Shimoda, S., Iwasaki, H., Shimono, N., Ayabe, T., Akashi, K. & Teshima, T. (2012) Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of -defensins. Blood, 120, 223–231.
- Eriguchi, Y., Uryu, H., Nakamura, K., Shimoji, S., Takashima, S., Iwasaki, H., Miyamoto, T., Shimono, N., Hashimoto, D., Akashi, K., Ayabe, T. & Teshima, T. (2013) Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation, 19, 1525–1529.
- Eriguchi, Y., Nakamura, K., Hashimoto, D., Shimoda, S., Shimono, N., Akashi, K., Ayabe, T. & Teshima, T. (2015) Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transplant Infectious Disease, 17, 702–706.
- Ferrara, J.L.M., Harris, A.C., Greenson, J.K., Braun, T.M., Holler, E., Teshima, T., Levine, J.E., Choi, S.W.J., Huber, E., Landfried, K., Akashi, K., Vander Lugt, M., Reddy, P., Chin, A., Zhang, Q., Hanash, S. & Paczesny, S. (2011) Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood, 118, 6702–6708.
- Fine, J.P. & Gray, R.J. (1999) A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94, 496.
- George, M.D., Wehkamp, J., Kays, R.J., Leutenegger, C.M., Sabir, S., Grishina, I., Dandekar, S. & Bevins, C.L. (2008) In vivo gene expression profiling of human intestinal epithelial cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics, 9, 209.
- Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., Spector, T.D., Clark, A.G. & Ley, R.E. (2014) Human genetics shape the gut microbiome. Cell, 159, 789–799.
- Goodrich, J.K., Davenport, E.R., Beaumont, M., Jackson, M.A., Knight, R., Ober, C., Spector, T.D., Bell, J.T., Clark, A.G. & Ley, R.E. (2016) Genetic determinants of the gut microbiome in UK twins. Cell Host & Microbe, 19, 731–743 A.
- Goodrich, J.K., Davenport, E.R., Clark, A.G. & Ley, R.E. (2017) The relationship between the human genome and microbiome comes into view. Annual Review of Genetics, 51, 413–433.
- Gulati, A.S., Shanahan, M.T., Arthur, J.C., Grossniklaus, E., von Furstenberg, R.J., Kreuk, L., Henning, S.J., Jobin, C. & Sartor, R.B. (2012) Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition. PLoS One, 7, e32403.
- Harris, A.C., Ferrara, J.L.M., Braun, T.M., Holler, E., Teshima, T., Levine, J.E., Choi, S.W., Landfried, K., Akashi, K., Vander Lugt, M., Couriel, D.R., Reddy, P. & Paczesny, S. (2012) Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood, 119, 2960–2963.
- Hayase, E., Hashimoto, D., Nakamura, K., Noizat, C., Ogasawara, R., Takahashi, S., Ohigashi, H., Yokoi, Y., Sugimoto, R., Matsuoka, S., Ara, T., Yokoyama, E., Yamakawa, T., Ebata, K., Kondo, T., Hiramine, R., Aizawa, T., Ogura, Y., Hayashi, T., Mori, H., Kurokawa, K., Tomizuka, K., Ayabe, T. & Teshima, T. (2017) R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. The Journal of Experimental Medicine, 214, 3507–3518.
- Holler, E., Butzhammer, P., Schmid, K., Hundsrucker, C., Koestler, J., Peter, K., Zhu, W., Sporrer, D., Hehlgans, T., Kreutz, M., Holler, B., Wolff, D., Edinger, M., Andreesen, R., Levine, J.E., Ferrara, J.L., Gessner, A., Spang, R. & Oefner, P.J. (2014) Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation, 20, 640–645.
- Jenq, R.R., Ubeda, C., Taur, Y., Menezes, C.C., Khanin, R., Dudakov, J.A., Liu, C., West, M.L., Singer, N.V., Equinda, M.J., Gobourne, A., Lipuma, L., Young, L.F., Smith, O.M., Ghosh, A., Hanash, A.M., Goldberg, J.D., Aoyama, K., Blazar, B.R., Pamer, E.G. & van den Brink, M.R. (2012) Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. The Journal of Experimental Medicine, 209, 903–911.
- Jenq, R.R., Taur, Y., Devlin, S.M., Ponce, D.M., Goldberg, J.D., Ahr, K.F., Littmann, E.R., Ling, L., Gobourne, A.C., Miller, L.C., Docampo, M.D., Peled, J.U., Arpaia, N., Cross, J.R., Peets, T.K., Lumish, M.A., Shono, Y., Dudakov, J.A., Poeck, H., Hanash, A.M., Barker, J.N., Perales, M.A., Giralt, S.A., Pamer, E.G. & van den Brink, M.R. (2015) Intestinal blautia is associated with reduced death from graft-versus-host disease. Biology of Blood and Marrow Transplantation, 21, 1373–1383.
- Menendez, A., Ferreira, R.B., & Finlay, B.B. (2010) Defensins keep the peace too. Nature Immunology, 11, 49–50.
- Karaesmen, E., Rizvi, A.A., Preus, L.M., McCarthy, P.L., Pasquini, M.C., Onel, K., Zhu, X., Spellman, S., Haiman, C.A., Stram, D.O., Pooler, L., Sheng, X., Zhu, Q., Yan, L., Liu, Q., Hu, Q., Webb, A., Brock, G., Clay-Gilmour, A.I., Battaglia, S., Tritchler, D., Liu, S., Hahn, T. & Sucheston-Campbell, L.E. (2017) Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant. Blood, 130, 1585–1596.
- Knights, D., Silverberg, M.S., Weersma, R.K., Gevers, D., Dijkstra, G., Huang, H., Tyler, A.D., van Sommeren, S., Imhann, F., Stempak, J.M., Huang, H., Vangay, P., Al-Ghalith, G.A., Russell, C., Sauk, J., Knight, J., Daly, M.J., Huttenhower, C. & Xavier, R.J. (2014) Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Medicine, 6, 107.
- Koyama, D., Murata, M., Hanajiri, R., Okuno, S., Kamoshita, S., Julamanee, J., Takagi, E., Hirano, D., Miyao, K., Sakemura, R., Goto, T., Hayakawa, F., Seto, A., Ozawa, Y., Miyamura, K., Terakura, S., Nishida, T. & Kiyoi, H. (2017) High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype. PLoS One, 12, e0185213.
- Levine, J.E., Huber, E., Hammer, S.T.G., Harris, A.C., Greenson, J.K., Braun, T.M., Ferrara, J.L.M. & Holler, E. (2013) Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality. Blood, 122, 1505–1509.
- Mastroianni, J.R. & Ouellette, A.J. (2009) Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. The Journal of Biological Chemistry, 284, 27848–27856.
- Masuda, K., Sakai, N., Nakamura, K., Yoshioka, S. & Ayabe, T. (2011) Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. Journal of Innate Immunity, 3, 315–326.
- Mathewson, N.D., Jenq, R., Mathew, A.V., Koenigsknecht, M., Hanash, A., Toubai, T., Oravecz-Wilson, K., Wu, S.-R., Sun, Y., Rossi, C., Fujiwara, H., Byun, J., Shono, Y., Lindemans, C., Calafiore, M., Schmidt, T.C., Honda, K., Young, V.B., Pennathur, S., van den Brink, M. & Reddy, P. (2016) Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology, 17, 505–513.
- Menendez, A., Willing, B.P., Montero, M., Wlodarska, M., So, C.C., Bhinder, G., Vallance, B.A. & Finlay, B.B. (2013) Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell a-defensins. Journal of Innate Immunity, 5, 39–49.
- Mukherjee, S., Zheng, H., Derebe, M.G., Callenberg, K.M., Partch, C.L., Rollins, D., Propheter, D.C., Rizo, J., Grabe, M., Jiang, Q.-X. & Hooper, L.V. (2014) Antibacterial membrane attack by a pore-forming intestinal C-type lectin. Nature, 505, 103–107.
- Rashidi, A., DiPersio, J.F., Sandmaier, B.M., Colditz, G.A. & Weisdorf, D.J. (2016) Steroids versus steroids plus additional agent in frontline treatment of acute graft-versus-host disease: a systematic review and meta-analysis of randomized trials. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 22, 1133–1137.
- Rayes, A., Morrow, A.L., Payton, L.R., Lake, K.E., Lane, A. & Davies, S.M. (2016) A genetic modifier of the gut microbiome influences the risk of graft-versus-host disease and bacteremia after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 22, 418–422.
- Riwes, M. & Reddy, P. (2018) Microbial metabolites and graft versus host disease. American Journal of Transplantation, 18, 23–29.
- Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., Stoel, M., Zhou, Y., Sodergren, E., Weinstock, G.M., Bevins, C.L., Williams, C.B. & Bos, N.A. (2009) Enteric defensins are essential regulators of intestinal microbial ecology. Nature Immunology, 11, 76–83.
- Scott, B.L., Pasquini, M.C., Logan, B.R., Wu, J., Devine, S.M., Porter, D.L., Maziarz, R.T., Warlick, E.D., Fernandez, H.F., Alyea, E.P., Hamadani, M., Bashey, A., Giralt, S., Geller, N.L., Leifer, E., Le-Rademacher, J., Mendizabal, A.M., Horowitz, M.M., Deeg, H.J. & Horwitz, M.E. (2017) Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. Journal of Clinical Oncology, 35, 1154–1161.
- Shono, Y., Docampo, M.D., Peled, J.U., Perobelli, S.M., Velardi, E., Tsai, J.J., Slingerland, A.E., Smith, O.M., Young, L.F., Gupta, J., Lieberman, S.R., Jay, H.V., Ahr, K.F., Porosnicu Rodriguez, K.A., Xu, K., Calarfiore, M., Poeck, H., Caballero, S., Devlin, S.M., Rapaport, F., Dudakov, J.A., Hanash, A.M., Gyurkocza, B., Murphy, G.F., Gomes, C., Liu, C., Moss, E.L., Falconer, S.B., Bhatt, A.S., Taur, Y., Pamer, E.G., van den Brink, M.R.M. & Jenq, R.R. (2016) Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Science Translational Medicine, 8, 339ra71–339ra71.
- Staffas, A., Burgos da Silva, M. & van den Brink, M.R.M. (2017) The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood, 129, 927–933.
- Sugi, Y., Takahashi, K., Kurihara, K., Nakano, K., Kobayakawa, T., Nakata, K., Tsuda, M., Hanazawa, S., Hosono, A. & Kaminogawa, S. (2017) α-Defensin 5 gene expression is regulated by gut microbial metabolites. Bioscience, Biotechnology, and Biochemistry, 81, 242–248.
- Turpin, W., Espin-Garcia, O., Xu, W., Silverberg, M.S., Kevans, D., Smith, M.I., Guttman, D.S., Griffiths, A., Panaccione, R., Otley, A., Xu, L., Shestopaloff, K., Moreno-Hagelsieb, G.; GEM Project Research Consortium, Paterson, A.D. & Croitoru, K. (2016) Association of host genome with intestinal microbial composition in a large healthy cohort. Nature Genetics, 48, 1413–1417.
- Vaishnava, S., Behrendt, C.L., Ismail, A.S., Eckmann, L. & Hooper, L.V. (2008) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proceedings of the National Academy of Sciences of the United States of America, 105, 20858–20863.
- Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R., Wakeland, E.K. & Hooper, L.V. (2011) The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science (New York, N.Y.), 334, 255–258.
- Verneris, M.R., Lee, S.J., Ahn, K.W., Wang, H.-L., Battiwalla, M., Inamoto, Y., Fernandez-Vina, M.A., Gajewski, J., Pidala, J., Munker, R., Aljurf, M., Saber, W., Spellman, S. & Koreth, J. (2015) HLA mismatch is associated with worse outcomes after unrelated donor reduced-intensity conditioning hematopoietic cell transplantation: an analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation, 21, 1783–1789.
- Weber, D., Jenq, R.R., Peled, J.U., Taur, Y., Hiergeist, A., Koestler, J., Dettmer, K., Weber, M., Wolff, D., Hahn, J., Pamer, E.G., Herr, W., Gessner, A., Oefner, P.J., van den Brink, M.R.M. & Holler, E. (2017a) Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 23, 845–852.
- Weber, D., Frauenschläger, K., Ghimire, S., Peter, K., Panzer, I., Hiergeist, A., Weber, M., Kutny, D., Wolff, D., Grube, M., Huber, E., Oefner, P., Gessner, A., Hehlgans, T., Herr, W. & Holler, E. (2017b) The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation. PLoS One, 12, e0185265.
- Whangbo, J., Ritz, J. & Bhatt, A. (2017) Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 52, 183–190.
- Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J. & Ouyang, W. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Medicine, 14, 282–289.